Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Shuaifuyuan No. 1, Dongcheng District, Beijing, 100730, China.
Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, 100730, China.
BMC Cancer. 2019 Aug 13;19(1):798. doi: 10.1186/s12885-019-6026-1.
We report an extremely rare case of vaginal clear cell carcinoma, which originated from the malignant transformation of vaginal adenosis without prenatal diethylstilbestrol (DES) exposure.
In this case, the patient was a Chinese woman with a history of two decades of intermittent vaginal pain, sexual intercourse pain and vaginal contact bleeding. On September 1, 2011, when the patient was 39 years old, a vaginal biopsy revealed vaginal adenosis. After intermittent drug and laser treatment, her symptoms did not improve. Four years later, on March 4, 2015, another vaginal biopsy for abnormal vaginal cytology revealed atypical vaginal adenosis. After treatment with sirolimus, her symptoms and abnormal vaginal cytology results persisted, and she underwent laparoscopic hysterectomy with bilateral salpingo-oophorectomy and excision of the vaginal lesions. One year after the hysterectomy, on August 15, 2017, the vaginal cytology results suggested atypical glandular cells, and a biopsy revealed vaginal clear cell carcinoma originating from the atypical vaginal adenosis. A wide local resection of the vaginal lesions was performed, followed by concurrent chemoradiotherapy. Regular follow-up over 16 months showed no evidence of the recurrence of vaginal adenosis or cancer.
Based on the evolution of a series of pathological evidence, we report the fourth case in the world of vaginal clear cell carcinoma originating from vaginal adenosis without prenatal DES exposure. Wide local excision with radiotherapy provided at least 16 months of disease-free survival.
我们报告了一例极为罕见的阴道透明细胞癌,该肿瘤起源于无产前己烯雌酚(DES)暴露的阴道腺病恶变。
本例患者为一名中国女性,病史 20 余年,表现为间断性阴道疼痛、性交痛和阴道接触性出血。2011 年 9 月 1 日,患者 39 岁时,阴道活检发现阴道腺病。间断药物和激光治疗后,其症状无改善。4 年后,即 2015 年 3 月 4 日,因异常阴道细胞学行阴道活检,结果提示非典型阴道腺病。给予西罗莫司治疗后,其症状及异常阴道细胞学结果仍持续存在,遂行腹腔镜子宫切除术+双侧附件切除术+阴道病变切除术。子宫切除术后 1 年,即 2017 年 8 月 15 日,阴道细胞学结果提示非典型腺细胞,活检发现阴道透明细胞癌来源于非典型阴道腺病。行阴道病变广泛局部切除术,并行同期放化疗。16 个月的定期随访未发现阴道腺病或癌症复发的证据。
基于一系列病理证据的演变,我们报告了世界上第 4 例无产前 DES 暴露的阴道透明细胞癌起源于阴道腺病。广泛局部切除联合放疗至少提供了 16 个月的无病生存。